Consolidated Condensed Statements of Equity-Q - USD ($)		Total	Noncontrolling Interest	Controlling Interest
Balance, at Dec. 31, 2014		$ 2,581,590,000	$ 295,431,000	$ 2,286,159,000
Net income/(loss)		(72,405,000)	2,758,000	(75,163,000)
Other comprehensive income/(loss)	[1]	19,087,000	0	19,087,000
Comprehensive income/(loss)		(53,318,000)	2,758,000	(56,076,000)
Cash dividends declared:
Preferred stock ($1,550 per share for the three months ended March 31, 2016 and 2015)		(1,550,000)	0	(1,550,000)
Common stock ($.07 and $.06 per share for the three months ended March 31, 2016 and 2015, respectively)		(14,159,000)	0	(14,159,000)
Common stock repurchased	[2]	(16,767,000)	0	(16,767,000)
Common stock issued for:
Stock options and restricted stock-equity awards		3,173,000	0	3,173,000
Stock-based compensation expense		3,024,000	0	3,024,000
Dividends declared-noncontrolling interest of subsidiary preferred stock		(2,758,000)	(2,758,000)	0
Tax benefit/(benefit reversal)-stock based compensation expense		22,000	0	22,000
Balance, at Mar. 31, 2015		2,499,257,000	295,431,000	2,203,826,000
Balance, at Dec. 31, 2015		2,639,586,000	295,431,000	2,344,155,000
Net income/(loss)		52,213,000	2,851,000	49,362,000
Other comprehensive income/(loss)	[1]	43,751,000	0	43,751,000
Comprehensive income/(loss)		95,964,000	2,851,000	93,113,000
Cash dividends declared:
Preferred stock ($1,550 per share for the three months ended March 31, 2016 and 2015)		(1,550,000)	0	(1,550,000)
Common stock ($.07 and $.06 per share for the three months ended March 31, 2016 and 2015, respectively)		(16,519,000)	0	(16,519,000)
Common stock repurchased	[2]	(75,763,000)	0	(75,763,000)
Common stock issued for:
Stock options and restricted stock-equity awards		157,000	0	157,000
Stock-based compensation expense		3,941,000	0	3,941,000
Dividends declared-noncontrolling interest of subsidiary preferred stock		(2,851,000)	(2,851,000)	0
Tax benefit/(benefit reversal)-stock based compensation expense		(17,000)	0	(17,000)
Balance, at Mar. 31, 2016		$ 2,642,948,000	$ 295,431,000	$ 2,347,517,000

[1] Due to the nature of the preferred stock issued by FHN and its subsidiaries, all components of Other comprehensive income/(loss) have been attributed solely to FHN as the controlling interest holder.

[2] 2016 and 2015 include $ 75.0 million and $ 15.8 million, respectively, repurchased under share repurchase program